FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 217 filers reported holding FATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,580,000 | -1.2% | 27,000 | 0.0% | 0.05% | +4.2% |
| Q3 2021 | $1,600,000 | -38.6% | 27,000 | -10.0% | 0.05% | -39.2% |
| Q2 2021 | $2,604,000 | +5.3% | 30,000 | 0.0% | 0.08% | +1.3% |
| Q1 2021 | $2,474,000 | -32.0% | 30,000 | -25.0% | 0.08% | -36.6% |
| Q4 2020 | $3,637,000 | +51.7% | 40,000 | -33.3% | 0.12% | +25.5% |
| Q3 2020 | $2,398,000 | +16.5% | 60,000 | 0.0% | 0.10% | +8.9% |
| Q2 2020 | $2,059,000 | +54.5% | 60,000 | 0.0% | 0.09% | +23.3% |
| Q1 2020 | $1,333,000 | -2.7% | 60,000 | -14.3% | 0.07% | +25.9% |
| Q4 2019 | $1,370,000 | +26.0% | 70,000 | 0.0% | 0.06% | +23.4% |
| Q3 2019 | $1,087,000 | -23.5% | 70,000 | 0.0% | 0.05% | -28.8% |
| Q2 2019 | $1,421,000 | +15.5% | 70,000 | 0.0% | 0.07% | +15.8% |
| Q1 2019 | $1,230,000 | +37.0% | 70,000 | 0.0% | 0.06% | +32.6% |
| Q4 2018 | $898,000 | -21.2% | 70,000 | 0.0% | 0.04% | -17.3% |
| Q3 2018 | $1,140,000 | +101.1% | 70,000 | +40.0% | 0.05% | +136.4% |
| Q2 2018 | $567,000 | – | 50,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
| Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
| Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
| Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
| Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
| Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
| DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
| Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
| Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |